{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:06:27Z","timestamp":1783595187391,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":1510,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1111\/ajt.15054","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T01:55:28Z","timestamp":1533606928000},"page":"2496-2505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Cost-effectiveness of hepatitis C\u2013positive donor kidney transplantation for hepatitis C\u2013negative recipients with concomitant direct-acting antiviral therapy"],"prefix":"10.1016","volume":"18","author":[{"given":"Gaurav","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman V.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1111\/ajt.15054_bib1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1600-6143.2010.03091.x","article-title":"Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients","volume":"10","author":"Kucirka","year":"2010","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15054_bib2","first-page":"51","article-title":"Outcomes associated with recipient and donor hepatitis C serology status after kidney transplantation in the United States: analysis of the USRDS\/UNOS database","author":"Bucci","year":"2004","journal-title":"Clin Transplants."},{"issue":"7","key":"10.1111\/ajt.15054_bib3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/01.tp.0000259725.96694.0a","article-title":"Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival","volume":"83","author":"Maluf","year":"2007","journal-title":"Transplantation."},{"issue":"4","key":"10.1111\/ajt.15054_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMp1505074","article-title":"Transplanting hepatitis C-positive kidneys","volume":"373","author":"Reese","year":"2015","journal-title":"N Engl J Med."},{"issue":"8948","key":"10.1111\/ajt.15054_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(95)90583-9","article-title":"A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group","volume":"345","author":"Pereira","year":"1995","journal-title":"Lancet."},{"issue":"6","key":"10.1111\/ajt.15054_bib6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00007890-199703270-00010","article-title":"Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement","volume":"63","author":"Bouthot","year":"1997","journal-title":"Transplantation."},{"issue":"7","key":"10.1111\/ajt.15054_bib7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJM199108153250702","article-title":"Transmission of hepatitis C virus by organ transplantation","volume":"325","author":"Pereira","year":"1991","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1111\/ajt.15054_bib8","doi-asserted-by":"crossref","first-page":"e13055","DOI":"10.1111\/ctr.13055","article-title":"Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: analysis of United States national data","volume":"31","author":"Gupta","year":"2017","journal-title":"Clin Transplant."},{"issue":"5","key":"10.1111\/ajt.15054_bib9","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/ajt.13620","article-title":"Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents","volume":"16","author":"Sawinski","year":"2016","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.15054_bib10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.kint.2017.10.024","article-title":"Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient","volume":"93","author":"Chute","year":"2018","journal-title":"Kidney Int."},{"key":"10.1111\/ajt.15054_bib11","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/tri.13118","article-title":"Impact of anti-HCV direct antiviral agents on graft function and immunosuppressive drug levels in kidney transplant recipients: a call to attention in the mid-term follow-up in a single-center cohort study","volume":"31","author":"Fernandez-Ruiz","year":"2018","journal-title":"Transpl Int."},{"issue":"4","key":"10.1111\/ajt.15054_bib12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.29258","article-title":"Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: results from the HCV-TARGET study","volume":"66","author":"Saxena","year":"2017","journal-title":"Hepatology."},{"issue":"24","key":"10.1111\/ajt.15054_bib13","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","author":"Goldberg","year":"2017","journal-title":"N Engl J Med."},{"issue":"8","key":"10.1111\/ajt.15054_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med."},{"issue":"suppl 1","key":"10.1111\/ajt.15054_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ajt.14557","article-title":"OPTN\/SRTR 2016 annual data report: kidney","volume":"18","author":"Hart","year":"2018","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.15054_bib16","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1111\/j.1523-1755.2005.00696.x","article-title":"The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation","volume":"68","author":"Gill","year":"2005","journal-title":"Kidney Int."},{"key":"10.1111\/ajt.15054_bib17","unstructured":"Centers for Medicare & Medicaid Services. NADAC (National Average Drug Acquisition Cost). https:\/\/healthdata.gov\/dataset\/nadac-national-average-drug-acquisition-cost. Accessed October 11, 2017."},{"key":"10.1111\/ajt.15054_bib18","unstructured":"Centers for Medicare & Medicaid Services. Medicare Provider Utilization and Payment Data: Inpatient. https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and-Reports\/Medicare-Provider-Charge-Data\/Inpatient.html. Accessed January 10, 2018."},{"key":"10.1111\/ajt.15054_bib19","unstructured":"United States Renal Data System. Annual Report. 2016. https:\/\/www.usrds.org\/2016\/view\/Default.aspx. Accessed October 11, 2017."},{"key":"10.1111\/ajt.15054_bib20","unstructured":"Centers for Medicare & Medicaid Services. Medicare Provider Utilization and Payment Data: Physician and Other Supplier (last updated on June 2017). Medicare Physician and Other Supplier Data. CY. 2015."},{"key":"10.1111\/ajt.15054_bib21","unstructured":"Bureau of Labor Statistics. Consumer Price Index: Archived Consumer Price Index Detailed Reports. August 2017. https:\/\/www.bls.gov\/cpi\/tables\/detailed-reports\/home.htm. Accessed October 11, 2017."},{"key":"10.1111\/ajt.15054_bib22","unstructured":"Bureau of Labor Statistics. Consumer Price Index: Consumer Price Index (CPI) Databases. https:\/\/www.bls.gov\/cpi\/data.htm. Accessed October 11, 2017."},{"issue":"9","key":"10.1111\/ajt.15054_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/tri.12954","article-title":"Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study","volume":"30","author":"Bhamidimarri","year":"2017","journal-title":"Transpl Int."},{"issue":"22","key":"10.1111\/ajt.15054_bib24","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection","volume":"376","author":"Bourliere","year":"2017","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1111\/ajt.15054_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/cid\/civ722","article-title":"Grazoprevir, elbasvir, and ribavirin for chronic hepatitis C virus genotype 1 infection after failure of pegylated interferon and ribavirin with an earlier-generation protease inhibitor: final 24-week results from C-SALVAGE","volume":"62","author":"Buti","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"4","key":"10.1111\/ajt.15054_bib26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/hep.29671","article-title":"Glecaprevir\/pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure","volume":"67","author":"Poordad","year":"2018","journal-title":"Hepatology."},{"key":"10.1111\/ajt.15054_bib27","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1097\/TP.0000000000002099","article-title":"Race, risk, and willingness of end-stage renal disease patients without hepatitis C (HCV) to accept an HCV-infected kidney transplant","volume":"102","author":"McCauley","year":"2018","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15054_bib28","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/ajt.14381","article-title":"The American Society of Transplantation consensus conference on the use of hepatitis C viremic donors in solid organ transplantation","volume":"17","author":"Levitsky","year":"2017","journal-title":"Am J Transplantation."},{"key":"10.1111\/ajt.15054_bib29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/TP.0000000000002033","article-title":"Use of organs from hepatitis C virus positive donors for uninfected recipients: a potential cost-effective approach to save lives?","volume":"102","author":"Trotter","year":"2018","journal-title":"Transplantation."},{"issue":"5","key":"10.1111\/ajt.15054_bib30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/TP.0000000000001410","article-title":"Use of HCV+ donors does not affect HCV clearance with directly acting antiviral therapy but shortens the wait time to kidney transplantation","volume":"101","author":"Sawinski","year":"2017","journal-title":"Transplantation."},{"issue":"3","key":"10.1111\/ajt.15054_bib31","first-page":"674","article-title":"Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients","volume":"55","author":"Vincenti","year":"1993","journal-title":"Transplantation."},{"issue":"3","key":"10.1111\/ajt.15054_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/TP.0b013e318255f839","article-title":"The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation","volume":"94","author":"Gheorghian","year":"2012","journal-title":"Transplantation."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15054","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522097349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522097349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.15054\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:21:15Z","timestamp":1761628875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522097349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1600613522097349"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15054","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of hepatitis C\u2013positive donor kidney transplantation for hepatitis C\u2013negative recipients with concomitant direct-acting antiviral therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}